1. Home
  2. CING vs XTKG Comparison

CING vs XTKG Comparison

Compare CING & XTKG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • XTKG
  • Stock Information
  • Founded
  • CING 2012
  • XTKG 1997
  • Country
  • CING United States
  • XTKG Singapore
  • Employees
  • CING N/A
  • XTKG 178
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • XTKG
  • Sector
  • CING Health Care
  • XTKG
  • Exchange
  • CING Nasdaq
  • XTKG NYSE
  • Market Cap
  • CING 15.3M
  • XTKG 13.7M
  • IPO Year
  • CING 2021
  • XTKG 2019
  • Fundamental
  • Price
  • CING $4.76
  • XTKG $0.99
  • Analyst Decision
  • CING Strong Buy
  • XTKG
  • Analyst Count
  • CING 2
  • XTKG 0
  • Target Price
  • CING $12.00
  • XTKG N/A
  • AVG Volume (30 Days)
  • CING 216.3K
  • XTKG 205.7K
  • Earning Date
  • CING 11-07-2024
  • XTKG 11-27-2024
  • Dividend Yield
  • CING N/A
  • XTKG N/A
  • EPS Growth
  • CING N/A
  • XTKG N/A
  • EPS
  • CING N/A
  • XTKG N/A
  • Revenue
  • CING N/A
  • XTKG $15,234,138.00
  • Revenue This Year
  • CING N/A
  • XTKG N/A
  • Revenue Next Year
  • CING N/A
  • XTKG N/A
  • P/E Ratio
  • CING N/A
  • XTKG N/A
  • Revenue Growth
  • CING N/A
  • XTKG 51.59
  • 52 Week Low
  • CING $1.80
  • XTKG $0.08
  • 52 Week High
  • CING $62.70
  • XTKG $2.14
  • Technical
  • Relative Strength Index (RSI)
  • CING 52.86
  • XTKG 49.71
  • Support Level
  • CING $4.27
  • XTKG $0.90
  • Resistance Level
  • CING $5.16
  • XTKG $1.38
  • Average True Range (ATR)
  • CING 0.42
  • XTKG 0.17
  • MACD
  • CING -0.01
  • XTKG -0.02
  • Stochastic Oscillator
  • CING 37.18
  • XTKG 23.92

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About XTKG X3 HOLDINGS CO LTD

X3 Holdings Co Ltd is company which is responsible for globally providing of Technology Solutions and Services across Diverse Industries that operates across four business segments: digital technologies, renewable energy, Cryptomining Operations, and agriculture technologies.

Share on Social Networks: